Haemophilia Centre Rhine Main

This study is testing a treatment called immune tolerance induction (ITI) in 300 people with haemophilia A who have developed inhibitors—antibodies that block the effectiveness of standard clotting factor therapy. The goal is to eliminate these inhibitors using high doses of indi…